223 related articles for article (PubMed ID: 31094020)
1. Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas.
Wang X; Wang Z; Zhang Y; Wang Y; Zhang H; Xie S; Xie P; Yu R; Zhou X
Cell Prolif; 2019 Jul; 52(4):e12636. PubMed ID: 31094020
[TBL] [Abstract][Full Text] [Related]
2. Golgi phosphoprotein 3 promotes glioma progression via inhibiting Rab5-mediated endocytosis and degradation of epidermal growth factor receptor.
Zhou X; Xie S; Wu S; Qi Y; Wang Z; Zhang H; Lu D; Wang X; Dong Y; Liu G; Yang D; Shi Q; Bian W; Yu R
Neuro Oncol; 2017 Nov; 19(12):1628-1639. PubMed ID: 28575494
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of GOLPH3 siRNA and gefitinib by cationic lipid-PLGA nanoparticles improves EGFR-targeted therapy for glioma.
Ye C; Pan B; Xu H; Zhao Z; Shen J; Lu J; Yu R; Liu H
J Mol Med (Berl); 2019 Nov; 97(11):1575-1588. PubMed ID: 31673738
[TBL] [Abstract][Full Text] [Related]
4. GOLPH3 promotes glioma progression via facilitating JAK2-STAT3 pathway activation.
Wu S; Fu J; Dong Y; Yi Q; Lu D; Wang W; Qi Y; Yu R; Zhou X
J Neurooncol; 2018 Sep; 139(2):269-279. PubMed ID: 29713848
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase D2 promotes the proliferation of glioma cells by regulating Golgi phosphoprotein 3.
Zhou X; Xue P; Yang M; Shi H; Lu D; Wang Z; Shi Q; Hu J; Xie S; Zhan W; Yu R
Cancer Lett; 2014 Dec; 355(1):121-9. PubMed ID: 25218347
[TBL] [Abstract][Full Text] [Related]
6. Golgi Phosphoprotein 3 Promotes Wls Recycling and Wnt Secretion in Glioma Progression.
Lu D; Zhang H; Fu J; Qi Y; Wang X; Wu S; Zhou X; Yu R
Cell Physiol Biochem; 2018; 47(6):2445-2457. PubMed ID: 29990993
[TBL] [Abstract][Full Text] [Related]
7. GOLPH3 regulates the migration and invasion of glioma cells though RhoA.
Zhou X; Zhan W; Bian W; Hua L; Shi Q; Xie S; Yang D; Li Y; Zhang X; Liu G; Yu R
Biochem Biophys Res Commun; 2013 Apr; 433(3):338-44. PubMed ID: 23500462
[TBL] [Abstract][Full Text] [Related]
8. Golgi Phosphoprotein 3 Inhibits the Apoptosis of Human Glioma Cells in Part by Downregulating N-myc Downstream Regulated Gene 1.
Li X; Li M; Tian X; Li Q; Lu Q; Jia Q; Zhang L; Yan J; Li X; Li X
Med Sci Monit; 2016 Oct; 22():3535-3543. PubMed ID: 27698340
[TBL] [Abstract][Full Text] [Related]
9. MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR.
Liu Y; Yang L; Liao F; Wang W; Wang ZF
Oncogene; 2020 Sep; 39(39):6190-6202. PubMed ID: 32820249
[TBL] [Abstract][Full Text] [Related]
10. GOLPH3 promotes glioblastoma cell migration and invasion via the mTOR-YB1 pathway in vitro.
Zhang X; Ding Z; Mo J; Sang B; Shi Q; Hu J; Xie S; Zhan W; Lu D; Yang M; Bian W; Zhou X; Yu R
Mol Carcinog; 2015 Nov; 54(11):1252-63. PubMed ID: 25156912
[TBL] [Abstract][Full Text] [Related]
11. Expression of the Golgi phosphoprotein-3 gene in human gliomas: a pilot study.
Li XY; Liu W; Chen SF; Zhang LQ; Li XG; Wang LX
J Neurooncol; 2011 Nov; 105(2):159-63. PubMed ID: 21499727
[TBL] [Abstract][Full Text] [Related]
12. Chemoresistant tumor cell lines display altered epidermal growth factor receptor and HER3 signaling and enhanced sensitivity to gefitinib.
Servidei T; Riccardi A; Mozzetti S; Ferlini C; Riccardi R
Int J Cancer; 2008 Dec; 123(12):2939-49. PubMed ID: 18803287
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma.
Zhang J; Zhang J; Qiu W; Zhang J; Li Y; Kong E; Lu A; Xu J; Lu X
J Neurooncol; 2018 Sep; 139(3):547-562. PubMed ID: 29774498
[TBL] [Abstract][Full Text] [Related]
14. The knocking down of the oncoprotein Golgi phosphoprotein 3 in T98G cells of glioblastoma multiforme disrupts cell migration by affecting focal adhesion dynamics in a focal adhesion kinase-dependent manner.
Arriagada C; Luchsinger C; González AE; Schwenke T; Arriagada G; Folch H; Ehrenfeld P; Burgos PV; Mardones GA
PLoS One; 2019; 14(2):e0212321. PubMed ID: 30779783
[TBL] [Abstract][Full Text] [Related]
15. Golgi phosphoprotein 3 (GOLPH3) promotes endometrial carcinoma cell invasion and migration by regulating the epithelial-mesenchymal transition.
Wen Y; Tan X; Wu X; Wu Q; Qin Y; Liang M; Ran G; Gu H; Xie R
Cancer Biomark; 2019; 26(1):21-30. PubMed ID: 31322544
[TBL] [Abstract][Full Text] [Related]
16. EGFR tyrosine kinase inhibition radiosensitizes and induces apoptosis in malignant glioma and childhood ependymoma xenografts.
Geoerger B; Gaspar N; Opolon P; Morizet J; Devanz P; Lecluse Y; Valent A; Lacroix L; Grill J; Vassal G
Int J Cancer; 2008 Jul; 123(1):209-16. PubMed ID: 18386816
[TBL] [Abstract][Full Text] [Related]
17. Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma progression by activating mTOR signaling pathway.
Liu H; Wang X; Feng B; Tang L; Li W; Zheng X; Liu Y; Peng Y; Zheng G; He Q
BMC Cancer; 2018 Jun; 18(1):661. PubMed ID: 29914442
[TBL] [Abstract][Full Text] [Related]
18. Kaempferol suppresses glioma progression and synergistically enhances the antitumor activity of gefitinib by inhibiting the EGFR/SRC/STAT3 signaling pathway.
Zhou J; Liu Y; Chen J; Xiong N; Yi D
Drug Dev Res; 2023 May; 84(3):592-610. PubMed ID: 36852868
[TBL] [Abstract][Full Text] [Related]
19. Lentivirus mediated GOLPH3 shRNA inhibits growth and metastasis of esophageal squamous cancer.
Wang Q; Wang X; Zhang CB
Asian Pac J Cancer Prev; 2013; 14(9):5391-6. PubMed ID: 24175832
[TBL] [Abstract][Full Text] [Related]
20. GOLPH3 inhibition reverses oxaliplatin resistance of colon cancer cells via suppression of PI3K/AKT/mTOR pathway.
Yu T; An Q; Cao XL; Yang H; Cui J; Li ZJ; Xiao G
Life Sci; 2020 Nov; 260():118294. PubMed ID: 32818544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
